The past, present, and future of HIV prevention: Integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention

Annual Review of Clinical Psychology

Volumn 5, Issue , 2009, Pages 143-167

  Rotheram Borus, Mary Jane ^a   Swendeman, Dallas ^a   Chovnick, Gary ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Chronic disease; Dissemination; Evidence based interventions; Review

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTATION; BEHAVIOR THERAPY; BUSINESS ETHICS; CIRCUMCISION; COMMERCIAL PHENOMENA; CONDOM; CONSUMER; CONTRACEPTION; COST EFFECTIVENESS ANALYSIS; DIAPHRAGM; DIFFUSION; DRUG ABUSE; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; FAMILY; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; MEDICAL TECHNOLOGY; METHODOLOGY; OUTCOME ASSESSMENT; PROPHYLAXIS; REVIEW; RISK; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; UNITED STATES; UNSPECIFIED SIDE EFFECT; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WELLBEING; COST BENEFIT ANALYSIS; ECONOMICS; FORECASTING; HIGH RISK BEHAVIOR; INCIDENCE; INTEGRATIVE MEDICINE; MALE; PREVALENCE; PREVENTIVE HEALTH SERVICE; STATISTICS; UTILIZATION REVIEW;

AIDS VACCINES; ANTI-RETROVIRAL AGENTS; BIOMEDICAL ENHANCEMENT; CIRCUMCISION, MALE; CONDOMS; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; FORECASTING; HIV INFECTIONS; HUMANS; INCIDENCE; INTEGRATIVE MEDICINE; MALE; PREVALENCE; PREVENTIVE HEALTH SERVICES; RISK-TAKING;

EID: 67650126123     PISSN: 15485943     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.clinpsy.032408.153530     Document Type: Review

References (177)

1. Albarracin D, Gillette JC, Earl AN, Glasman LR, Durantini MR, et al. 2005. A test of major assumptions about behavior change: a comprehensive look at the effects of passive and active HIV-prevention interventions since the beginning of the epidemic. Psychol. Bull. 131(6):856-897 (Pubitemid 43022716)
2. Anderson JE. 2003. Condom use and HIV risk among U.S. adults. Am. J. Public Health 93(6):912-914 (Pubitemid 38480219)
3. Aral S, Peterman TA. 2002. STD diagnosis and treatment as an HIV prevention strategy. In Beyond Condoms: Alternative Approaches to HIV Prevention, ed. A O'Leary, pp. 77-90. New York: Kluwer Acad./Plenum
4. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. 2005. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2(11):e298 (Pubitemid 41735779)
5. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. 2007. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet 369(9562):643-656 (Pubitemid 46281312)
6. Beaudin CL, Chambré SM. 1996. HIV/AIDS as a chronic disease: emergence from the plague model. Am. Behav. Sci. 39(6):684-706 (Pubitemid 126061448)
7. Bell E, Mthembu P, O'Sullivan S, Moody K. 2007. Sexual and reproductive health services and HIV testing: perspectives and experiences of women and men living with HIV and AIDS. Reprod. Health Matters 15(29 Suppl.):113-135 (Pubitemid 46771204)
8. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, et al. 2006. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 10(4 Suppl.):S85-93 (Pubitemid 44198368)
9. Blankenship KM, Friedman S, Dworkin S, Mantell J. 2006. Structural interventions: concepts, challenges and opportunities for research. J. Urban Health 83(1):59-72 (Pubitemid 44337043)
10. Bower JL, Christensen CM. 1995. Disruptive technologies: catching the wave. Harv. Bus. Rev. 73(1):43-53
11. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, et al. 2006. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm. Rep. 55(RR-14):1-17
12. Calif. Healthcare Found. 2006. The minute clinic movement: model for the future or 60 seconds of fame? July 18. http://www.chcf.org/press/view.cfm? itemID=123240
13. Capacity Proj. 2008. Improving resource-use through the integration of HIV/AIDS services. Washington, DC: U.S. Agency Intl. Dev. http://www. capacityproject.info/en/work/strategy4/
14. Celum C, Wald A, Hughes J, Sanchez J, Reid S, et al. 2008. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomized, double-blind, placebo-controlled trial. Lancet 371(9630):2109-2119 (Pubitemid 351902179)
15. Chan M. 2007. Address to the Eleventh Global Forum for Health Research. Fostering new models of science development and collaboration. Curr. Opin. HIV AIDS 3(4):477-480
16. Chandra PS, Desai G, Ranjan S. 2005. HIV and psychiatric disorders. Indian J. Med. Res. 121(4):451-467
17. Chesney MA, Smith AW. 1999. Critical delays in HIV testing and care: the potential role of stigma. Am. Behav. Sci. 42(7):1162-1174
18. Chigwedere P, Seage GR, Lee T, Essex M. 2008. Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. AIDS Res. Hum. Retroviruses 24(6):827-837 (Pubitemid 351871673)
19. Chorpita BF, Becker KD, Daleiden EL. 2007. Understanding the common elements of evidence-based practice: misconceptions and clinical examples. J. Am. Acad. Child Adolesc. Psychiatry 46(5):647-652
20. Chorpita BF, Daleiden EL, Weisz JR. 2005. Identifying and selecting the common elements of evidence-based interventions: a distillation and matching model. Ment. Health Serv. Res. 7(1):5-20
21. Coates TJ, Szekeres G. 2004. A plan for the next generation of HIV prevention research: seven key policy investigative challenges. Am. Psychol. 59(8):747-757 (Pubitemid 39526345)
22. Cohen DA, Wu S-Y, Farley TA. 2004. Comparing the cost-effectiveness of HIV prevention interventions. J. Acquir. Immune Defic. Syndr. 37(3):1404-1414
23. Collins C, Harshbarger C, Sawyer R, Hamdallah M. 2006a. The diffusion of effective behavioral interventions project: development, implementation, and lessons learned. AIDS Educ. Prev. 18(4):5-20 (Pubitemid 44440943)
24. Collins PY, Holman AR, Freeman MC, Patel V. 2006b. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS 20(12):1571-1582 (Pubitemid 44162398)
25. Cooper D, Cahn P, Lewin S, Kaldor J, McClure C, et al. 2007. The Sydney declaration: a call to scale up research. Lancet 370(9581):7-8 (Pubitemid 47017450)
26. Copenhaver MM, Johnson BT, Lee IC, Harman JJ, Carey MP, et al. 2006. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J. Subst. Abuse Treat. 31(2):163-171
27. Corey L, Wald A, Celum CL, Quinn TC. 2004. The effect of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 35(5):435-445 (Pubitemid 38420652)
28. Creer TL, Holroyd KA, Glasgow RE, Smith TW. 2004. Health psychology. In Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, ed. MJ Lambert, 15:697-742. New York:Wiley. 5th ed.
29. Crepaz N, Horn AK, Rama SM, Griffin T, Deluca JB, et al. 2007. The efficacy of behavioral interventions in reducing HIV risk sex behaviors and incident sexually transmitted diseases in black and Hispanic sexually transmitted disease clinic patients in the United States: a meta-analytic review. Sex Transm. Dis. 34(6):319-332 (Pubitemid 46816776)
30. Crepaz N, Lyles CM, Wolitski RJ, Passin WF, Rama SM, et al. 2006. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 20(2):143-157
31. Crosby RA, Holtgrave DR. 2006. Will sexual risk behavior increase after being vaccinated for AIDS? Int. J. STD AIDS 17(3):180-184
32. Curtis VA, Garbrah-Aidoo N, Scott B. 2007. Ethics in public health research: masters of marketing. Bringing private sector skills to public health partnerships. Am. J. Public Health 97(4):634-641
33. De Cock KM, Bunnell R, Mermin J. 2006. Unfinished business-expanding HIV testing in developing countries. N. Engl. J. Med. 354(5):440-442 (Pubitemid 43200293)
34. Delius P, Glaser C. 2005. Sex, disease and stigma in South Africa: historical perspectives. Afr. J. AIDS Res. 4(1):29-36 (Pubitemid 41645300)
35. DelliFraine JL, Dansky KH. 2008. Home-based telehealth: a review and meta-analysis. J. Telemed. Telecare 14(2):62-66
36. Detels R. 2001. The role of epidemiology in challenging the HIV/AIDS pandemic. J. Epidemiol. 11(2):95-102
37. DeVol R, Bedroussian A. 2007. An Unhealthy America: The Economic Burden of Chronic Disease. Los Angeles, CA: Milken Inst.
38. Dickson NP, van Roode T, Herbison P, Paul C. 2008. Circumcision and risk of sexually transmitted infections in a birth cohort. J. Pediatr. 152(3):383-387 (Pubitemid 351231889)
39. Dorfman L, Wallack L, Woodruff K. 2005. More than a message: framing public health advocacy to change corporate practices. Health Educ. Behav. 32(3):320-336 (Pubitemid 40756610)
40. Durantini MR, Albarracin D, Mitchell AL, Earl AN, Gillette JC. 2006. Conceptualizing the influence of social agents of behavior change: a meta-analysis of the effectiveness of HIV-prevention interventionists for different groups. Psychol. Bull. 132(2):212-248
41. Dworkin SL, Ehrhardt AA. 2007. Going beyond "ABC" to include "GEM": critical reflections on progress in the HIV/AIDS epidemic. Am. J. Public Health 97(1):13-18
42. Dworkin SL, Pinto RM, Hunter J, Rapkin B, Remien RH. 2008. Keeping the spirit of community partnerships alive in the scale up of HIV/AIDS prevention: critical reflections on the roll out of DEBI (diffusion of effective behavioral interventions). Am. J. Community Psychol. 42(1-2):51-59
43. Eke AN, Mezoff JS, Duncan T, Sogolow ED. 2006a. Reputationally strong HIV prevention programs: lessons from the front line. AIDS Educ. Prev. 18(2):163-175
44. Eke AN, Neumann MS, Wilkes AL, Jones PL. 2006b. Preparing effective behavioral interventions to be used by prevention providers: the role of researchers during HIV prevention research trials. AIDS Educ. Prev. 18(4 Suppl. A):44-58
45. Epping-Jordan J, Bengoa R, Kawar R, Sabaté E. 2001. The challenge of chronic conditions: WHO responds. BMJ 323(7319):947-948 (Pubitemid 33016039)
46. Epstein H. 2007. The Invisible Cure: Africa, the West, and the Fight Against AIDS. New York: Farrar, Straus, Giroux
47. Feachem RGA. 2004. The research imperative: fighting AIDS, TB and malaria. Trop. Med. Int. Health 9(11):1139-1141
48. Fisher JD, Fisher WA, Cornman DH, Amico RK, Bryan A, et al. 2006. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J. Acquir. Immune Defic. Syndr. 41(1):44-52 (Pubitemid 41786018)
49. Flay BR, Biglan A, Boruch RF, Castro FG, Gottfredson D, et al. 2005. Standards of evidence: criteria for efficacy, effectiveness and dissemination. Prev. Sci. 6(3):151-175
50. Foss AM, Watts CF, Vickerman P, Heise L. 2004. Condoms and prevention of HIV. Are essential and effective, but additional methods are also needed. BMJ 329(7459):185-186
51. Fowler MG, Lampe MA, Jamieson DJ, Kourtis AP, Roger MF. 2007. Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am. J. Obstet. Gynecol. 197(3 Suppl.):S3-9
52. Freeman E, Weiss H, Glynn JR, Cross PL, Whitworth J, et al. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20(1):73-83 (Pubitemid 41818117)
53. Freudenberg N, Fahs M, Galea S, Greenberg A. 2006. The impact of New York City's 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic. Am. J. Public Health 96(3):424-434 (Pubitemid 43320687)
54. Galbraith JS, Stanton B, Boekeloo B, King W, Desmond S, et al. 2008. Exploring implementation and fidelity of evidence-based behavioral interventions for HIV prevention: lessons learned from the Focus on Kids Diffusion Case Study. Health Educ. Behav. doi:10.1177/1090198108315366
55. Garland AF, Hawley KM, Brookman-Frazee L, Hurlburt MS. 2008. Identifying common elements of evidence-based psychosocial treatments for children's disruptive behavior problems. J. Am. Acad. Child Adolesc. Psychiatry 47(5):505-514 (Pubitemid 351591599)
56. Girard MP, Osmanov SK, Kieny MP. 2006. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 24(19):4062-4081
57. Glasgow RE, Lichtenstein E, Marcus AC. 2003. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy to effectiveness transition. Am. J. Public Health 93(8):1261-1267 (Pubitemid 38480188)
58. Glynn M, Rhodes P. 2005. Estimated HIV prevalence in the United States at the end of 2003. Presented at Natl. HIV Prev. Conf., June 12-15, Atlanta, GA
59. Goldstein MG, Whitlock EP, DePue J. 2004. Multiple behavioral risk factor interventions in primary care: summary of research evidence. Am. J. Prev. Med. 27(Suppl. 1):61-79 (Pubitemid 38953341)
60. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. 2007. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet 369(9562):657-666 (Pubitemid 46298897)
61. Gray RH, Wawer MJ. 2007. Randomized trials of HIV prevention. Lancet 370(9583):200-201
62. Green LW, Glasgow RE. 2006. Evaluating the relevance, generalization, and applicability of research. Eval. Health Prof. 29(1):126-153
63. Green LW, McAllister RG, Peterson KW, Travis JW. 2008. Male circumcision is not the HIV "vaccine" we have been waiting for. Future HIV Ther. 2(3):193-199
64. Greenwald JL, Hall J, Skolnik PR. 2006a. Approaching the CDC's guidelines on the HIV testing of inpatients: physician-referral versus nonreferral-based testing. AIDS Patient Care STDS 20(5):311-317 (Pubitemid 43800960)
65. Greenwald JL, Rich CA, Bessega S, Posner MA, Maeda JL, et al. 2006b. Evaluation of the Centers for Disease Control and Prevention's recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: Who are we missing? Mayo Clin. Proc. 81(4):452-458
66. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, et al. 1995. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 346(8974):530-536
67. Hallett TB, White PJ, Garnett GP. 2007. Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm. Infect. 83(Suppl. 1):i55-60
68. Halperin D. 2008. Putting a plague in perspective. N.Y. Times, Jan. 1
69. Harling G, Wood R, Beck EJ. 2005. Efficiency of interventions in HIV infection, 1994-2004. Dis. Manag. Health Outcomes 13(6):371-394 (Pubitemid 41783776)
70. Herbst JH, Sherba JT, Crepaz N, Deluca JB, Zohrabyan L, et al. 2005. A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J. Acquir. Immune Defic. Syndr. 39(2):228-241 (Pubitemid 40741123)
71. Herek GM, Capitanio JP, Widaman KF. 2003. Stigma, social risk, and health policy: public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychol. 22(5):533-540
72. Hillier SL, Moench T, Shattock R, Black R, Reichelderfer P, et al. 2005. In vitro and in vivo: the story of nonoxynol 9. J. Acquir. Immune Defic. Syndr. 39(1):1-8
73. Hogg R, Lima V, Sterne JAC, Grabar S, Battegay M, et al. 2008. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372(9635):293-299
74. Holtgrave DR, McGuire J. 2007. Impact of counseling in voluntary counseling and testing programs for persons at risk for or living with HIV infection. Clin. Infect. Dis. 45(Suppl. 4):S240-43
75. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahow D. 1998. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J. Acquir. Immune Defic. Syndr. 18(Suppl. 1):S133-38 (Pubitemid 28304481)
76. Ingram BL, Flannery D, Elkavich A, Rotheram-Borus MJ. 2008. Common processes in evidence-based adolescent HIV prevention programs. AIDS Behav. 12(3):374-383
77. Jain N, Yusuf H, Wortley PM, Euler GL, Walton S, Stokley S. 2004. Factors associated with receiving hepatitis B vaccination among high-risk adults in the United States: an analysis of the National Health Review Survey, 2000. Fam. Med. 36(7):480-486 (Pubitemid 38924646)
78. Janossy G, Shapiro H. 2008. Overview: simplified cytometry for routine monitoring of infectious diseases. Cytometry B Clin. Cytom. 74B(Suppl. 1):S6-10 (Pubitemid 351569267)
79. Jensen PS. 2003. Commentary: the next generation is overdue. J. Am. Acad. Child Adolesc. Psychiatry 42(5):527-530
80. Johnson BT, Carey MP, Chaudoir SR, Reid AE. 2006. Risk reduction for persons living with human immunodeficiency virus: research synthesis of randomized controlled trials, 1993-2004. J. Acquir. Immune Defic. Syndr. 41(5):642-650
81. Kaisernetwork.org. 2005. 16th annual black church week of prayer for healing of AIDS begins. Kaiser Daily HIV/AIDS Rep., March 7
82. Kaisernetwork.org. 2008. NIAID Director Fauci cancels planned HIV vaccine trial. Kaiser Daily HIV/AIDS Rep., July 18
83. Kaldor JM, Guy R, Wilson D. 2008. Efficacy trials of biomedical strategies to prevent HIV infection. Curr. Opin. HIV AIDS 3(4):504-508
84. Kalichman SC. 2008. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions. Psychosom. Med. 70(5):593-597
85. Kaminski JW, Valle LA, Filene JH, Boyle CL. 2008. A meta-analytic review of components associated with parent training program effectiveness. J. Abnorm. Child Psychol. 36(4):567-589
86. Keiser O, Orrell C, Egger M, Wood R, Brinkof MWG, et al. 2008. Public-health and individual approaches to antiretroviral therapy: Township South Africa and Switzerland compared. PLoS Med. 5(7):e148
87. Kelly JA. 1999. Community-level interventions are needed to prevent new HIV infections. Am. J. Public Health 89(3):299-301
88. Kennedy P, Hopwood M, Duff J. 2001. Psychological management of chronic illness and disability. In Psychology and Psychiatry: Integrating Medical Practice, ed. JMilgrom, GD Burrows, 183-212. Chichester, UK: Wiley
89. Kippax S. 2008. Understanding and integrating the structural and biomedical determinants of HIV infection: a way forward for prevention. Curr. Opin. HIV AIDS 3:489-494
90. Kirby D. 2003. Presentation on USAID's ABC Study, Oct. 23. Washington, DC: USAID
91. Klein D, Hurley LB, Merrill D, Quesenberry CP. 2003. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J. Acquir. Immune Defic. Syndr. 32(2):143-152 (Pubitemid 36222715)
92. Lagakos SW, Gable AR. 2008. Challenges to HIV prevention-seeking effective measures in the absence of a vaccine. N. Engl. J. Med. 358(15):1543-1545
93. Leibowitz AA, Desmond K, Belin T. 2009. Male circumcision in the United States: determinants and policy implications. Am. J. Public Health. In press
94. Li L, Wu Z, Wu S, Zhaoc Y, Jia M, et al. 2007. HIV-related stigma in health care settings: a survey of service providers in China. AIDS Patient Care STDs 21(10):753-762 (Pubitemid 47614393)
95. Luo C, Akwara P, Ngongo N, Doughty P, Gass R, et al. 2007. Global progress in PMTCT and pediatric HIV care and treatment in low- and middle-income countries in 2004-2005. Reprod. Health Matters 15(30):179-189 (Pubitemid 47559136)
96. Mackie NE, Coker RJ. 2000. Post-exposure prophylaxis following nonoccupational exposure to HIV: risks, uncertainties, and ethics. Int. J. STD AIDS 11(7):424-427
97. MacPhail CL, Pettifor A, Coates T, Rees H. 2008. "You must do the test to know your status": attitudes to HIV voluntary counseling and testing for adolescents among South African youth and parents. Health Educ. Beh. 35(1):87-104
98. Madon T, Hofman KJ, Kupfer L, Glass RI. 2007. Public health implementation science. Science 318(5857):1728-1729
99. Maibach EW, Van Duyn MA, Bloodgood B. 2006. A marketing perspective on disseminating evidence-based approaches to disease prevention and health promotion. Prev. Chronic Dis. 3(3):A97
100. Mantell JE, Dworkin SL, Exner TM, Hoffman S, Smit JA, et al. 2006. The promise and limitations of female-initiated methods of HIV/STI protection. Soc. Sci. Med. 63(8):1998-2009 (Pubitemid 44278348)
101. Marks G, Crepaz N, Janssen RS. 2006. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20(10):1447-1450 (Pubitemid 43948252)
102. Marks G, Crepax N, Senterfitt JW, Janssen RS. 2005. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. J. Acquir. Immune Defic. Syndr. 39(4):446-453
103. Marlatt GA, George WH. 1998. Relapse prevention and the maintenance of optimal health. In The Handbook of Health Behavior Change, ed. SA Shumaker, EB Schron, pp. 33-58. New York: Springer
104. Martin JN, Roland ME, Neilands TB, Krone MR, Bamberger JD, et al. 2004. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS 18(5):787-792
105. McClure SM, Laibson DI, Loewenstein G, Cohen JD. 2004. Separate neural systems value immediate and delayed monetary rewards. Science 306(5695):503-507
106. McGinnis JM, Foege WH. 1993. Actual causes of death in the United States. JAMA 270(8):2207-2212
107. McKleroy VS, Galbraith JS, Cummings B, Jones P, Harshbarger C, et al. 2006. Adapting evidence-based behavioral interventions for new settings and target populations. AIDS Educ. Prev. 18(Suppl. A):59-73 (Pubitemid 44440947)
108. McKoy JN, Peterson R. 2006. Reducing African-American women's sexual risk: Can churches play a role? J. Natl. Med. Assoc. 98(7):1151-1159
109. Merson MH, O'Malley J, Serwadda D, Apisuk C. 2008. The history and challenge of HIV prevention. Lancet 372(9637):475-488
110. Miller RL, Shinn M. 2005. Learning from communities overcoming difficulties in dissemination of prevention and promotion efforts. Am. J. Community Psychol. 35(3-4):169-183 (Pubitemid 40684863)
111. Minnis AM, Padian NS. 2005. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sex Transm. Infect. 81(3):193-200
112. Montaner JSG, Hogg R, Wood E, Kerr T, Tyndall M, et al. 2006. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 268(9534):531-536 (Pubitemid 44142776)
113. Moore JP, Klasse PJ, Dolan MJ, Ahuja SK. 2008. AIDS/HIV: a STEP into darkness or light? Science 320(5877):753-755
114. Moore JS, Rogers M. 2002. Female-controlled prevention technologies. In Beyond Condoms: Alternative Approaches to HIV Prevention, ed. A O'Leary, pp. 47-76. New York: Kluwer/Plenum
115. Morris BJ. 2007. Why circumcision is a biomedical imperative for the 21(st) century. BioEssays 29(11):1147-1158 (Pubitemid 350057386)
116. Munro S, Lewin S, Swart T, Volmink J. 2007. A review of health behavior theories: How useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health 7(147):104-119 (Pubitemid 47091753)
117. Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, et al. 2001. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann. Intern. Med. 135(1):17-26 (Pubitemid 32619279)
118. Myer L, Rebe K, Morroni C. 2007. Missed opportunities to address reproductive health care needs among HIV-infected women in antiretroviral therapy programmes. Trop. Med. Int. Health 12:1484-1489 (Pubitemid 350212714)
119. Nair J, Strecher V, Fagerlin A, Ubel P, Resnicow K, et al. 2008. Screening experiments and the use of fractional factorial designs in behavioral intervention research. Am. J. Public Health 98(8):1354-1359
120. Natl. Inst. Mental Health Intervent. Workgroup. 2001. An integrated framework for preventive and treatment interventions. Presented at Natl. Inst. Mental Health Intervent. Workgroup Meet., Nov. 1, Washington, DC
121. Neumann MS, Johnson WD, Semaan S, Flores SA, Peersman G, et al. 2002. Review and meta-analysis of HIV prevention intervention research for heterosexual adult populations in the United States. J. Acquir. Immune Defic. Syndr. 30(Suppl. 1):S106-17 (Pubitemid 34774069)
122. Newman PA, Duan N, Lee SJ, Rudy ET, Seiden DS, et al. 2006. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Vaccine 24(12):2094-2101 (Pubitemid 43255152)
123. Newman PA, Duan N, Rudy ET, Anton PA. 2004a. Challenges for HIV vaccine dissemination and clinical trial recruitment: If we build it, will they come? AIDS Patient Care STDs 18(12)691-701 (Pubitemid 40066161)
124. Newman PA, Duan N, Rudy ET, Johnston-Roberts K. 2004b. HIV risk and prevention in a postvaccine context. Vaccine 22(15-16):1954-1963 (Pubitemid 38581065)
125. Obermeyer CM, Osborn M. 2007. The utilization of testing and counseling for HIV: a review of the social and behavioral evidence. Am. J. Public Health 97(10):1762-1774 (Pubitemid 351182283)
126. Padian NS, Van Der Straten A, Ramjee G, Chipato T, de Bruyn G, et al. 2007. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomized controlled trial. Lancet 370(9583):251-261 (Pubitemid 47069513)
127. Padian S, Buvé A, Balks J, Serwadda D, Cates WJr. 2008. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet 372(9638):585-599
128. Parker RG, Easton D, Klein CH. 2000. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS 14(Suppl. 1):S22-32 (Pubitemid 30679804)
129. Patrick ME, Maggs JL, Abar CC. 2007. Reasons to have sex, personal goals, and sexual behavior during the transition to college. J. Sex Res. 44(3):240-249
130. Paxton LA, Hope T, Jaffe HW. 2007. Pre-exposure prophylaxis for HIV infection: What if it works? Lancet 370(9581):89-93 (Pubitemid 47033881)
131. Pinkerton SD, Holtgrave DR. 2000. How HIV treatment advances affect the cost-effectiveness of prevention. Med. Decis. Making 20(1):89-94
132. Pinkerton SF, Johnson-Masotta AP, Holtgravbe DR, Farnham PG. 2001. Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. AIDS 15(7):917-928
133. Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, et al. 2008. Reassessing HIV prevention. Science 320(5877):749-750
134. Poundstone KE, Strathdee SA, Celentano DD. 2004. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol. Rev. 26:22-35 (Pubitemid 38856475)
135. Pozniak A. 2004. Post-exposure prophylaxis for sexual exposure to HIV. Curr. Opin. Infect. Dis. 17(1):39-40 (Pubitemid 39089971)
136. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 342:921-929
137. Rapkin B, Trickett EJ. 2005. Comprehensive dynamic trial designs for behavioral prevention research with communities: overcoming inadequacies of the randomized controlled trial paradigm. In Community Interventions and AIDS, ed. EJ Trickett, W Pequenaut, pp. 249-277 New York: Oxford Univ. Press
138. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. 2005. The social structural production of HIV risk among injecting drug users. Soc. Sci. Med. 61(5):1026-1044 (Pubitemid 40805548)
139. Rojanapithayakorn W. 2006. The 100% condom use program in Asia. Reprod. Health Matters 14(28):41-52 (Pubitemid 44708766)
140. Rotheram-Borus MJ, Duan N. 2003. Next generation of preventive interventions. J. Am. Acad. Child Adolesc. Psychiatry 42(5):518-526
141. Rotheram-Borus MJ, Duan N, Flannery D. 2004a. Interventions that are CURRES: cost-effective, useful, realistic, robust, evolving, and sustainable. In Facilitating Pathways: Care, Treatment, and Prevention in Child and Adolescent Mental Health, ed. H Remschmidt, ML Belfer, I Goodyer, pp. 235-244 Heidelberg, Germ.: Springer-Verlag Telos
142. Rotheram-Borus MJ, Flannery D, Lester Rice E. 2004b. Prevention for HIV-positive families. J. Acquir. Immune Defic. Syndr. 37(Suppl. 2):S133-34
143. Rotheram-Borus MJ, Lee MB, Gwadz M, Draimin B. 2001. An intervention for parents with AIDS and their adolescent children. Am. J. Public Health 91(8):1294-1302 (Pubitemid 32708873)
144. Rotheram-Borus MJ, Leibowitz AA, Etzel MA. 2006b. Routine, rapid HIV testing. AIDS Educ. Prev. 18(3):273-280
145. Rotheram-Borus MJ, Lester P, Song J, Lin YY, Leonard NR, et al. 2006a. Intergenerational benefits of family-based HIV interventions. J. Consult. Clin. Psychol. 74(3):622-627 (Pubitemid 44128241)
146. Rotheram-Borus MJ, Swendeman D, Flannery D, Rice E, Adamson D, Ingram B. 2008. Common factors in effective HIV prevention programs. AIDS Beh. ePub ahead of print, Oct. 2
147. Sachs JD. 2008. Common wealth. Time, March 13
148. Schechter M, do Lago RF, Mendelsohn AB, Moreira RI, Moulton LH, et al. 2004. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J. Acquir. Immune Defic. Syndr. 35(5):519-525
149. Schmit J. 2006. Could walk-in retail clinics help slow rising health costs? USA Today, Aug. 28
150. Schneider H, Hlophe H, van Rensburg D. 2006. Community health workers and the response to HIV/IDS in South Africa: tensions and prospects. Health Policy Plan. 23(3):179-187
151. Semaan S, Des Jarlais DC, Sogolow E, Johnson W, Hedges L, et al. 2002. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J. Acquir. Immune Defic. Syndr. 30(Suppl. 1):S73-93 (Pubitemid 34774067)
152. Shah A. 2008. Health issues. http:/www.globalissues.org/health
153. Shoptaw S, Rotheram-Fuller E, Landovitz RJ, Wang JM, Moe A, et al. 2008. Non-occupational post exposure prophlaxis as a biobehavioral HIV-prevention intervention. AIDS Care 20(3):376-381
154. Sikkema KJ, Anderson ES, Kelly JA, Winett RA, Gore-Felton C, et al. 2005. Outcomes of a randomized, controlled community-level HIV prevention intervention for adolescents in low-income housing developments. AIDS 19(14):1509-1516 (Pubitemid 41400697)
155. Sikkema KJ, Kelly JA, Winett RA, Solomon LJ, Cargill VA, et al. 2000. Outcomes of a randomized community level HIV prevention intervention forwomenliving in 18 low-income housing developments. Am. J. Public Health 90(1):57-63
156. Singer MC, Erickson PI, Badiane L, Diaz R, Ortiz D, et al. 2006. Syndemics, sex and the city: understanding sexually transmitted diseases in social and cultural context. Soc. Sci. Med. 63(8):2010-2021 (Pubitemid 44278354)
157. Singh S, Darroch JE, Bankole A. 2003. A, B and C in Uganda: the roles of abstinence, monogamy and condom use in HIV decline. Reprod. Health Matters 12(23):129-131
158. Smoak ND, Scott-Sheldon LA, Johnson BT, Carey MP. 2006. Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants. J. Acquir. Immune Defic. Syndr. 41(3):374-384
159. Sørensen T, Rivett U, Fortuin J. 2008. A review of ICT systems for HIV/AIDS and antiretroviral treatment management in South Africa. J. Telemed. Telecare 14(1):37-41
160. Sumartojo E. 2000. Structural factors in HIV prevention: concepts, examples, and implications for research. AIDS 14(Suppl. 1):S3-10 (Pubitemid 30679802)
161. Sumartojo E, Doll L, Holtgrave D, Gayle H, Merson M. 2000. Enriching the mix: incorporating structural factors into HIV prevention. AIDS 14(Suppl. 1):S1-2 (Pubitemid 30679801)
162. UNAIDS. 2004. HIV prevention and protection efforts are failing women and girls. Geneva: UNAIDS. http:/www.aegis.org/news/unaids/2004/UN040201.html
163. UNAIDS. 2008. AIDS Epidemic Update: 2008. Geneva: UNAIDS
164. Van Donk M. 2006. "Positive" urban futures in sub-Saharan Africa: HIVAIDS and the need for ABC (A Broader Conceptuatization). Environ. Urban. 18(1):155-175
165. Varghese B, Peterson TA, Holtgrave DR. 1999. Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS 13(13):1745-1751 (Pubitemid 30015723)
166. Vijayakumar G, Mabude Z, Smit J, Beksinska M, Lurie M. 2006. A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence. Int. J. STD AIDS 17(10):652-659 (Pubitemid 44611145)
167. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, et al. 2008. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N. Engl. J. Med. 358(15):1560-1571
168. Weis P, Schmid G, De Cock K. 2008. Who will bridge the HIV treatment-prevention gap? J. Infect Dis. 198(2):293-294 (Pubitemid 352019296)
169. Weisner TS. 2002. Ecocultural understanding of children's developmental pathways. Hum. Dev. 45:275-281
170. Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, et al. 2008a. Male circumcision for HIV prevention: from evidence to action? AIDS 22(5):567-574 (Pubitemid 351640589)
171. Weiss HA, Wasserheit JN, Barnabas RV, Hayes RJ, Abu-Raddad LJ. 2008b. Persisting with prevention: the importance of adherence for HIV prevention. Emerg. Themes Epidemiol. 5(1):8
172. West SG, Duan N, Pequegnat W, Gaist P, Des Jarlais DC. 2008. Alternatives to the randomized controlled trial. Am. J. Public Health 98(8):1359-1366
173. Willison KD, Andrews GJ. 2005. The potential of public health to enhance chronic disease management. Public Health 119(12):1130-1132 (Pubitemid 41662604)
174. Wilson DP, Coplan PM, Wainberg MA, Blower SM. 2008. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc. Natl. Acad. Sci. USA 105:9835-9840
175. Wise J, Operario D. 2008. Adherence to antiretroviral therapy: a systematic review. AIDS Patient Care STDs 22(6):495-504
176. World Health Org. 2007. World Health Report 2006: Annex Table 3. Geneva: World Health Org. http:/www.who.int/whr/2006/annex/en/index.html
177. Youle M, Wainberg MA. 2003. Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy. J. Int. Assoc. Physicians AIDS Care 2(3):102-105